Clin2
NCT07731139Possibly a fitNot yet recruiting

Testing a new medicine for people with obesity

Obesity

Part of Hormones & metabolism clinical trials.

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
120 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • Your body mass index (BMI) is between 30.0 and 40.0.
  • You have had a stable weight for at least 3 months before joining.
  • You do not have diabetes or serious heart, liver, kidney, stomach, or mental health conditions.
  • You may have mild conditions like high cholesterol or blood pressure that are controlled.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07291232Recruiting· Phase 1
Study of an injected drug for adults with obesity

This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.

Anaheim, California
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07754474Not yet recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT07575932Recruiting· Phase 2
Testing New Weight Loss Medications PF-08653945 and PF-08653944

This study tests two new experimental medications designed to help adults lose weight and improve weight-related health conditions like high blood pressure and sleep apnea. Participants will take one of these medications to see if it's safe and effective.

Chandler, Arizona

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.